We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.

August 14, 2018

Innovation and Mindful Implementations Driving the Future Health - HealthXL Global Gathering London 2018

Events
Hanna Phelan
&

This week we celebrated HealthXL’s fourth anniversary with our member community in London at our Global Gathering in partnership with Imperial College Health Partners and Silicon Valley Bank (SVB). The event has a rich history of bringing together industry leaders who are revolutionizing modern heath, including world class health system representatives, clinicians, investors, pharma executives and start-ups, and this gathering was no exception.

At this year’s gathering, some key themes populated multiple panels, key-notes and coffee break discussion including:

  1. Each day we are moving closer to genuine implementation of patient centered care
  2. Adopting innovation from other sectors and geographies is integral to success and crucial in reducing wasted efforts and capital
  3. Evidence will never go out of style

For those who couldn’t make the gathering and attendees looking to revisit the shared learnings, we have put together a roundup of some of the salient perspectives and participants below:

New Models of Care: Chatbots and Digital Therapeutics

The event’s kick off session on chatbots featured practicing NHS clinicians, futurists and innovators leading the charge in building products to address the need for smart triaging and decision support. There was unanimous agreement that while there is great opportunity to reduce unnecessary readmissions through supportive roles and even the eventual takeover of entire pathways, the industry needs to be patient and not expect the finished product to appear overnight.

"We expect AI and Chatbots to be perfect 100% of the time, but we know and accept that humans make mistakes. So, are we setting the wrong standard for now?" - Dr. Indra Joshi, NHS England

Chatbots offer the chance to deliver on the empowerment and democratization that we have been promised by digital health – allowing easy access to health information and clinical decision support to empower individuals. Evidence is difficult to pin down in the chatbots space, but the panel stressed the need to rigorously evaluate the honest impact of the offering for it to truly reach scale.

Empathy and a human touch will always be needed – chatbots will not act as an outright substitute for clinical care and human understanding. The panel raised the point that where chatbots can be particularly useful is caring for individuals who are missing out on diagnoses and treatment because of access barriers like stigma. When it comes to sexual and mental health this could be a breakthrough.

The session concluded with participants taking a look into the future of chatbots and AI supported health systems. The panelists agreed that chatbots will be a part of a broader systemic innovation aimed at meeting patients where they are, supporting intersystems management and relieving unnecessary burden from primary care services.

Frugal Innovation: Looking Beyond Traditional Borders

Participants:

Professor Darzi is a leading voice in the field of global health policy and innovation, most recently holding the Paul Hamlyn Chair of Surgery at Imperial College London, the Royal Marsden Hospital and the Institute of Cancer Research. He is also the Director of the Institute of Global Health Innovation at Imperial College London and Chair of Imperial College Health Partners.

This session reflected a running theme across the gathering – the need to look beyond traditional borders for new insights and ideas. Frugal innovation according to Dr. Ara Darzi is necessary if we are going to reform the healthcare system. Looking to environments that have been forced to innovate across the globe, particularly in low and middle income contexts, gives us a firm reminder on the root of innovation – necessity.

During the conversation Dr. Darzi spoke about the difficulties he has faced in driving adoption around robotic innovations for laparoscopic surgery, citing the challenge as similar to trying to “teach old dogs news tricks.” While he recognized that any new technologies may face initial skepticism, he warned about letting a lack of understanding get in the way of innovation, stating “you can question the validity of the technological innovations we have in healthcare now, but that shouldn’t stop us from innovating." He also emphasized the critical role education can plan in the innovation process. He highlighted the importance of clearly and consistently communicating back the value of innovations and new models of care to the clinical community, and to the public, even if there is a risk of failure.

Returning to the topic of frugal innovation (the art of doing more with less), the elephant in the room –the economics of innovation – remained center stage. Dr. Darzi addressed the issue stating that not all initiatives require finding new funding pathways and new capital, but existing money needs to utilized more efficiently. For example, leveraging existing resources and assets that are widely available to drive change, borrow proven technologies in one sector and adapt them to make new products in healthcare. In this instance, reinventing the wheel is a fruitless exercise.

Precision Medicine and Deep Learning Discussions

The Future of Population Health

Deep Learning Discussion How are we learning from health data of various forms to inform better drug discovery, medication management and treatment at every stage of a disease?

The Global Gathering’s Deep Learning and Precision Medicine sessions both mapped the potential across the continuum of human health and disease from personalising wellness plans and health approaches based on one’s genetic ethnic insights and on the other end of the spectrum how drugs are being discovered and repurposed with time on our side through deep learning capabilities.

The discussion around Deep Learning addressed the large scale collection of genetic data across populations in Asia and England and the great potential it holds for disease prediction and early intervention, with new drug developments catering to rare conditions or offering more targeted therapy for existing conditions, the conversation also addressed its potential for understanding correlations between human populations. Genomics Medicine England and Genome Asia 100k are both collecting hundreds of thousands of data points to enable initiatives exactly like these.

"How can precision medicine be precise if we don’t precisely know who we are" - Dr Stephan Schuster, Professor of Biological Sciences, Nanyang Technical University (NTU)

The Deep Learning panel outlined the use cases of deep learning, which served as a perfect continuation to the earlier discussion on large datasets to enable personalized medicine. Without shyness or hesitation, the group voiced concerns (or lack thereof) around data sharing, and professed their love for the UK (NHS) as a hub for innovation in this space.

"We have seen the ability of AI to assist the healthcare provider to arrive at a correct assessment of a patient’s status. Artificial intelligence will not supplant human physicians, rather assist healthcare providers to be more efficient and accurate." - Joanne Hackett, Chief Commercial Officer, Genomics England

HealthXL Global Gatherings showcase innovation on a global platform by bringing together people with ideas, resources and desire to contribute to the evolution of healthcare and this year’s London event was no exception. We look forward to continuing the conversations and the collaborations with our members at our next event in San Francisco on October 4th

Event Report

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

Ready to read more? HealthXL members can access the full peak of the report on the HealthXL Community Hub.

Not yet a member of HealthXL? Download your 11 page snapshot of the report.

Download your 11 page snapshot

Connect with peers and share insights

Don't miss out on the discussion of the latest insights and reports on digital health. Meet with peers and take a deep dive for 75 minutes. Unlike at webinars, you can freely exchange experiences and insights to solve challenges and design the future of DTx.

Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Adoption of Prescription DTx: Best Practices & Challenges

24th May @ 3:00PM AWST / 8:00AM GMT

A company might be able to create excellent digital therapeutics (DTx), but it won't have much of an impact if no one uses them. Join your peers in this meeting to discuss how to approach the problem and how some have already solved it. 

Featuring
Anish Shindore
Anish Shindore
Founder & Managing Partner, GSD Health
Hannes Klöpper
Hannes Klöpper
CEO, HelloBetter
Featuring
Anish Shindore
Anish Shindore
Founder & Managing Partner, GSD Health
Hannes Klöpper
Hannes Klöpper
CEO, HelloBetter
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Masterclass: DTx Reimbursement Success in Fully-insured Health Plans vs. Self-insured

31st May @ 10:45AM EDT

Are you a DTx or Pharma company seeking to successfully navigate both fully-insured and self-insured health plan segments to get your DTx products reimbursed in the US? Join this interactive masterclass led by biopharma and DTx reimbursement expert Mike Pace to learn more about this topic and share your experience with the group.

Featuring
Michael Pace
Michael Pace
CEO & Founder at PalmHealth.co
Featuring
Michael Pace
Michael Pace
CEO & Founder at PalmHealth.co
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Pharma - DTx: What Does Success Look Like?

2nd June @ 10:45AM EDT

In theory, Digital Therapeutics (DTx) and pharma are natural bedfellows, with both looking for commercially viable ways to connect with patients and improve outcomes. Join HealthXL in this meeting to dive deeper into this topic.

Featuring
Rick Bartels
Rick Bartels
Managing Partner , DTxCC
Anish Shindore
Anish Shindore
Founder & Managing Partner, GSD Health
Featuring
Rick Bartels
Rick Bartels
Managing Partner , DTxCC
Anish Shindore
Anish Shindore
Founder & Managing Partner, GSD Health
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Masterclass: How to Navigate DiGA in Germany? A Real Experience from a Digital Health Company

8th June @ 10:30AM EDT

Regulatory clearance and the right commercialization model for a digital health product are key components of success in this rapidly growing space. Join this interactive masterclass led by Dr Victor Stephani to dive deeper into this topic and discuss the matter further with your peers in this field.

Featuring
Dr. Victor Stephani
Dr. Victor Stephani
Chief of Staff, HelloBetter
Featuring
Dr. Victor Stephani
Dr. Victor Stephani
Chief of Staff, HelloBetter

Are you a HealthXL Member? See the Full Report Here

Non-HealthXL Member? You can purchase the report HERE

HealthXL Digital Health Meetings

Want to join the discussion now?

Join our Digital Health Meetings and take a deep dive for 75 minutes into topics like digital therapeutics, patient support, telehealth, clinical trials, dermatology and many more. These Meetings are not regular webinars: No audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And with a free account on our Community Hub, you stay connected and up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.

Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Adoption of Prescription DTx: Best Practices & Challenges

24th May @ 3:00PM AWST / 8:00AM GMT

A company might be able to create excellent digital therapeutics (DTx), but it won't have much of an impact if no one uses them. Join your peers in this meeting to discuss how to approach the problem and how some have already solved it. 

Featuring
Anish Shindore
Anish Shindore
Founder & Managing Partner, GSD Health
Hannes Klöpper
Hannes Klöpper
CEO, HelloBetter
Featuring
Anish Shindore
Anish Shindore
Founder & Managing Partner, GSD Health
Hannes Klöpper
Hannes Klöpper
CEO, HelloBetter
Digital Mental Health & Neurology
Digital Mental Health & Neurology
Digital Mental Health & Neurology
Digital Mental Health & Neurology

Evidence Generation Strategy for Digital Health in Neurology

24th May @ 10:45AM EDT

Most neurological conditions are complex diseases with no disease-modifying therapies. Join HealthXL in this meeting to discuss this further.

Featuring
Richelle Flanagan
Richelle Flanagan
Founder at My Moves Matter
Paul Wicks
Paul Wicks
Independent Consultant, Wicks Digital Health
Featuring
Richelle Flanagan
Richelle Flanagan
Founder at My Moves Matter
Paul Wicks
Paul Wicks
Independent Consultant, Wicks Digital Health
Digital Health in Oncology
Digital Health in Oncology
Digital Health in Oncology
Digital Health in Oncology

Sprint: Virtual Care in Oncology: HCP and Patient Adoption (Part 1)

25th May @ 10:45 AM EDT

Are you struggling with getting HCPs and patients to adopt your digital health solution in oncology? Apply now to join this series of two meetings to discuss this topic further and learn from your peers.

Featuring
Carole Tremonti
Carole Tremonti
VP Clinical Strategy, Project Ronin
Maike Schmitz
Maike Schmitz
Oncology Lead, RoX Health
Featuring
Carole Tremonti
Carole Tremonti
VP Clinical Strategy, Project Ronin
Maike Schmitz
Maike Schmitz
Oncology Lead, RoX Health
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery

Masterclass: Clinical Evidence for Digital Health: Standards and Expectations

31st May @10:45 AM EDT

Digital health vendors often seek payer collaborations, and solid clinical evidence is often needed to support this pathway. Join this interactive masterclass led by Jordan Silberman (Director of Clinical Analytics and Research, Digital Care Delivery, Anthem, Inc.) to engage with your others in this field and discuss this matter further.

Featuring
Jordan Silberman, MD, PhD
Jordan Silberman, MD, PhD
Director of Clinical Analytics and Research, Digital Care Delivery, Anthem, Inc.
Featuring
Jordan Silberman, MD, PhD
Jordan Silberman, MD, PhD
Director of Clinical Analytics and Research, Digital Care Delivery, Anthem, Inc.

What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.